Iridian Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q1
Sell
-15,600
Closed -$793K 83
2014
Q4
$793K Buy
+15,600
New +$793K 0.01% 47